LHC Group (LHCG) Expected to Announce Earnings of $0.60 Per Share
Wall Street brokerages forecast that LHC Group (NASDAQ:LHCG) will announce earnings per share (EPS) of $0.60 for the current quarter, Zacks reports. Four analysts have made estimates for LHC Group’s earnings. The lowest EPS estimate is $0.57 and the highest is $0.65. LHC Group reported earnings of $0.54 per share during the same quarter last year, which would indicate a positive year over year growth rate of 11.1%. The firm is expected to announce its next earnings results after the market closes on Wednesday, November 1st.
According to Zacks, analysts expect that LHC Group will report full-year earnings of $2.40 per share for the current year, with EPS estimates ranging from $2.36 to $2.50. For the next fiscal year, analysts anticipate that the company will post earnings of $2.64 per share, with EPS estimates ranging from $2.60 to $2.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. During the same period in the previous year, the firm earned $0.52 EPS. The firm’s revenue was up 15.1% compared to the same quarter last year.
Several brokerages have commented on LHCG. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a report on Wednesday. Royal Bank Of Canada restated a “buy” rating and issued a $70.00 target price on shares of LHC Group in a research report on Wednesday, September 6th. Robert W. Baird restated a “hold” rating and issued a $63.00 target price on shares of LHC Group in a research report on Tuesday, September 12th. Jefferies Group LLC restated a “buy” rating and issued a $65.00 target price on shares of LHC Group in a research report on Friday, June 9th. Finally, BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. LHC Group has an average rating of “Buy” and a consensus target price of $66.60.
LHC Group (LHCG) traded up 0.812% on Thursday, reaching $71.365. The company had a trading volume of 90,786 shares. LHC Group has a 1-year low of $32.04 and a 1-year high of $73.85. The stock has a market capitalization of $1.30 billion, a P/E ratio of 31.577 and a beta of 0.76. The stock’s 50 day moving average is $65.80 and its 200-day moving average is $61.43.
In related news, COO Donald Dwayne Stelly sold 2,650 shares of LHC Group stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 14.80% of the company’s stock.
A number of large investors have recently bought and sold shares of the business. USA Financial Portformulas Corp purchased a new stake in LHC Group in the second quarter valued at $662,000. Piedmont Investment Advisors LLC purchased a new stake in LHC Group in the second quarter valued at $220,000. Sterling Capital Management LLC raised its position in LHC Group by 24.3% in the second quarter. Sterling Capital Management LLC now owns 48,245 shares of the health services provider’s stock valued at $3,275,000 after purchasing an additional 9,426 shares during the period. Castleark Management LLC purchased a new stake in LHC Group in the second quarter valued at $7,661,000. Finally, Linscomb & Williams Inc. purchased a new stake in LHC Group in the second quarter valued at $2,268,000. Institutional investors own 85.93% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.